PerpEquities

SELLAS Life Sciences Group, Inc. (SLS) balance sheet

NASDAQ · Healthcare · Biotechnology · 13 employees · CEO Angelos Stergiou

Price
$14.69 +2.0%
Market cap
$2.78B
Enterprise value
$2.65B Data as of 2026-11-21
Last report
Q3 '26 filed 2026-11-12
Next report
2027-03-25 EPS est. -$0.05

At the end of Q3 '26 SELLAS Life Sciences Group, Inc. (SLS) held $135M in cash and short-term investments against $599K of debt incl. leases. Total assets $141M, total liabilities $9.29M, shareholders' equity $132M.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$2.53M$18.4M$9.15M$21M$13.9M$28.4M$25.3M$44.4M$71.9M$107M$138M$135M
Other current assets$100K$189K$203K$325K$100K$100K$381K$225K$223K$3.97M$4.06M$100K
Current assets$3.17M$21.5M$12.3M$24M$16.3M$32M$29.4M$49.1M$75.2M$111M$143M$139M
Property, plant & equipment (net)$858K$747K$633K$513K$925K$806K$683K$556K$963K$839K$710K$578K
Goodwill$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M$1.91M
Other non-current assets$275K$272K$270K$43K$466K$263K$261K$34K$257K$255K$253K$25K
Non-current assets$3.05M$2.93M$2.82M$2.47M$3.31M$2.98M$2.86M$2.5M$3.13M$3.01M$2.88M$2.52M
Total assets$6.22M$24.4M$15.1M$26.5M$19.4M$35M$32.3M$51.6M$78.3M$114M$145M$141M
Liabilities
Accounts payable$5.64M$7.41M$6.33M$4.55M$3.5M$3.76M$3.34M$2.31M$2.95M$3.63M$3.09M$2.09M
Accrued expenses$6.12M$4.9M$3.34M$3.53M$3.65M$1.92M$1.03M$1.42M$1.75M$630K$1.16M$6.6M
Short-term debt$0$0$0$0$0$0$0$599K$544K$562K$580K$0
Other current liabilities$1.54M$1.64M$1.84M$1.96M$1.82M$653K$1.06M$1.6M$1.77M$1.63M$2.75M$0
Current liabilities$13.7M$14.4M$12M$10.6M$9.51M$6.89M$6M$5.93M$7.02M$6.46M$7.57M$9.29M
Long-term debt$0$0$0$0$0$0$0$0$457K$309K$157K$0
Lease obligations (non-current)$460K$313K$161K$0$457K$309K$157K$0$0$0$0$0
Non-current liabilities$460K$313K$161K$0$457K$309K$157K$0$457K$309K$157K$0
Total liabilities$14.2M$14.8M$12.2M$10.6M$9.97M$7.2M$6.16M$5.93M$7.47M$6.77M$7.73M$9.29M
Equity
Common stock & paid-in capital$3K$5K$5K$6K$7K$9K$10K$12K$15K$18K$20K$20K
Retained earnings-$217M-$227M-$234M-$241M-$248M-$254M-$261M-$267M-$275M-$283M-$293M-$303M
Shareholders' equity-$7.98M$9.68M$2.91M$15.9M$9.47M$27.8M$26.1M$45.6M$70.9M$107M$138M$132M
Debt
Total debt (incl. leases)$906K$801K$692K$576K$1M$870K$737K$599K$1M$871K$737K$599K
Net debt (debt - cash)-$1.62M-$17.6M-$8.46M-$20.5M-$12.9M-$27.5M-$24.6M-$43.8M-$70.9M-$106M-$138M-$134M

Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30

Data as of 2026-11-21